A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Hideyuki Arita, Kai Yamasaki, Yuko Matsushita, +50

Acta Neuropathologica Communications

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

Kenji Fujimoto, Hideyuki Arita, Kaishi Satomi, +24

Acta Neuropathologica

Neuro-oncologySomatic VariantMedicineGeneticsPathology +7

TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations

Hideyuki Arita, Yuko Matsushita, Ryunosuke Machida, +48

Acta Neuropathologica Communications

Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma

Takahide Nejo, Hirokazu Matsushita, Takahiro Karasaki, +21

Cancer Immunology Research

Radiomics Analysis for Glioma Malignancy Evaluation Using Diffusion Kurtosis and Tensor Imaging

Satoshi Takahashi, Wataru Takahashi, Shota Tanaka, +11

International Journal of Radiation Oncology*Biology*Physics

Neuro-oncologyRadiation OncologyEngineeringOncologic ImagingMedical Imaging +13

Genetic and epigenetic stability of oligodendrogliomas at recurrence

Koki Aihara, Akitake Mukasa, Genta Nagae, +21

Acta Neuropathologica Communications

Distinct molecular profile of diffuse cerebellar gliomas

Masashi Nomura, Akitake Mukasa, Genta Nagae, +23

Acta Neuropathologica

Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma

Ryohei Otani, Akitake Mukasa, Masahiro Shin, +5

Journal of neurosurgery

DNA demethylation is associated with malignant progression of lower-grade gliomas

Masashi Nomura, Kuniaki Saito, Koki Aihara, +24

Scientific Reports

12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors

Kaishi Satomi, Hirokazu Takami, Shintaro Fukushima, +26

Neuro-Oncology